XW013W5
Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5
| Pos | Category | Selected Element & Definition |
|---|---|---|
| X | Section |
New Technology
|
| W | Body System |
Anatomical Regions
|
| 0 | Operation |
Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
|
| 1 | Body System / Region |
Subcutaneous Tissue
|
| 3 | Approach |
Percutaneous
|
| W | Device / Substance / Technology |
COVID-19 Vaccine Booster
|
| 5 | Qualifier |
New Technology Group 5
|